ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...

Researchers have made the first single cell map of the gene regulatory networks that drive heart failure, revealing crucial information to help develop better heart failure treatments.

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

The American Heart Association recently presented Tift Regional Medical Center with two awards honoring care that reflects ...

Adults who have heart failure with a left ventricular ejection fraction of 40% or more face a high risk of hospitalization for heart failure and cardiovascular death. People who have heart failure ...

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

A clinical trial found that a polypill improved heart function, increased adherence to guideline-recommended medications, and ...

An increasing proportion of patients with heart failure receive a combination of four medications shown to improve prognosis and recommended in guidelines. However, there is still room for improving ...

Scientists from leading heart organizations around the world have released an updated guide that changes how doctors identify ...

Leading cardiovascular societies have developed the second universal definition of heart failure that updates how it is classified and identified, hoping to improve diagnosis and management.